FDA Investigator CDR Rochelle B Young, RPh, MSA

CDR Rochelle B Young, RPh, MSA has inspections in 12 countries as of 29 Sep 2023. CDR Rochelle B Young, RPh, MSA has collaborated with a combinined 6677 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
135
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan, India, United States of America, China, France, Germany, United Kingdom of Great Britain and Northern Ireland, Israel, Belgium, Italy, Poland, Netherlands
Co-Investigator(s):
Acton, Adam S Freeman, Adetutu M Gidado, Aditi S Thakur, Alan P Kurtzberg, Alberto A Viciedo, Alicia K Mckinsey, Alla Dubrovsky, Allen F Hall, Amir Alavi, Ana Maria Osorio, MD, Anastasia I Onuorah, Anastasia M Shields, Andersoneric, Andrei Perlloni, Andrew K Haack, PhD, Andrew W Harmon, Angel K Sandhu, Angela E Glenn, Anh M Lac, Anita Narula, PhD, Anna M Brannen, Arindam Dasgupta, PhD, Arlene M Badillo, Ashar P Parikh, Azza Talaat, Barbara M Frazier, Bernice F Hirsch, Bo Chi, PhD, Bonita S Chester, Brandy D Brown, Brandy N Lepage, Bruce H Mccullough, Bryan S Roddy, Candace Y Gomez Broughton, Candice C Mandera, Candido Torres, Carl A Huffman, III, Carl Lee, Carla J Lundi, Carolyn A Renshaw, Carr, Caryn M Everly, Caryn M Mcnab, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Rochelle Byoung Rph, MSA, CDR Thomas R Berry, PPh, Celeste K Wong, Charanjeet Jassal, Charisse K Green, Charles R Bonapace, PhD, Chelsea N Sealey, Cheryl A Clausen, Christine M Smith, Courtney N Long, Craig A Garmendia, Cynthia Jim, CSO, Daniel C Geffin, Daniel J Roberts, Daniel L Aisen, Darlene B Almogela, David A Lum, David G Eng, David R Heiar, Dawn C Olenjack, Deborah A Greco, Dennis Cantellops Paite, Devaughn Edwards, Diane L Raccasi, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Douglas A Campbell, Douglas C Kovacs, Douglas Florentino, Dr. Abhijit Raha, PhD, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edecia A Richards, Edwin Melendez, Eileen A Liu, Elizabeth Juarez, Elizabeth S Furukawa, Emal Wahab, Emmanuel Adu Gyamfi, Eric L Dong, BS, Eric W Anderson, Erika V Butler, Erin D Mccaffery, Erin L Mcfiren, Evelyn Wong, Farhana Khan, Felix Maldonado, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gayle S Lawson, Gene D Arcy, Gene R Gunn, George Pyramides, Gerald Mierle, Gerald N Mcgirl, DDS, Geraldine D Sanders, Geraldine Sanders, Gerardo Z Vazquez, German Rivera, Gina M Hall, Glen E Harelson, Greg K Keshishyan, Gregson A Joseph, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Henry K Lau, Heriberto Negron Rivera, Humberto Z Gomez, Hung H Do, MS, Italia Nappi, Ivis Lnegron Torres, Jalyn M Everly, James A Lane, James C Lee, PharmD, James C Maclaughlin, James C Yee, James I Giefer, James R Evans, Jannifer L Degroot, Javier E Santos, Jeanne A Young, Jeanne J Thai, Jeffrey D Meng, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Degroot, Jennifer L Huntington, Jennifer L Johnson, Jennifer M Gogley, Joanne Hosting, Joanne Hostings, Joey V Quitania, John A Gonzalez, John A Iwen, John D White, Jolanna A Norton, Jolene S Hedgecock, Jorge L Gonzalez, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Melendez, Joseph A Seitz, Joseph Kutze, PhD, Joseph P Iser, MD, Joslyn K Brunelle, PhD, Jude C Dikes, Juliane Kjung Lau, Julie A Rorberg, Julie A Stocklin, June P Page, Justin A Boyd, Karen D Phung, Karen Takahashi, Kari M Johansen, Karlygash I Yermukan, Katherine Szestypalow, Kathryn E King, Kavita K Lalwani, Keith O Webber, PhD, Keith Webber, PhD, Kellia N Hicks, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kenneth O Gee, PhD, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Kula N Jha, Lance M De Souza, MBA, Latorie S Jones, Laura Fontan, MS, Laurie Graham, Lawton W Lum, LCDR Jennifer H Rhyu, Leiyun Boone, PhD, Leonard H Lavi, Leongc, Li Hongpaul Yeh, PhD, Lija V Fellows, Lillie D Witcher, Liming Zhang, Linan Ha, PhD, Linda R Kuchenthal, Linda Thai, Linh Tu, Lisa R Hilliar, Lorna F Jones, Lucas B Leake, Lucila B Nwatu, Luis A Dasta, Lydia S Chan, Lynda L Perry, PhD, Maan S Abduldayem, Macropolk, Maida Henesian (NMI), Marcellinus D Dordunoo, Margaret A Smithers, Margaret M Annes, Maria Joselopez Barragan, PhD, Maridali De Leon Torres, Marie K Kinkade, Mariza M Jafary, Mark E Chan, Mark P Prusak, Mark W Babbitt, Marshalette Edwards, Marshalette O Edwards, Mary Ewilkerson Brinsko, Mary R Hole, Massoud Motamed, Mathew T Thomas, MD, Matthew B Casale, Matthew R Clabeaux, Matthew R Sleeter, Maxwell Van Tassell, PhD, Maxyne T Lam, Mei Chiung J Huang, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael D Kawalek, Michael J Kuchta, Michael L Casner, Michael R Goga, Michele L Obert, Michelle D Haamid, Michelle Rfrazier Jessen, PhD, Miguel A Martinez, Mihaly S Ligmond, Milos Dokmanovic, PhD, Milva E Melendez, Milva E Meléndez, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Monique C Lo, Mra Davism, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Myla D Chapman, Nadeem I Chaudhry, Natalia Pripuzova, PhD, Naveen B Walker, Nicholas L Hunt, Nicholas L Paulin, Nicola M Fenty Stewart, Noreen Muniz, Nympha V Florendo, Omotunde O Osunsanmi, Parul M Patel, Patrice S Hall, Patricia F Hughes, PhD, Paul A Bonneau, Paul M Kawamoto, Paula A Trost, Peter E Baker, Prabhu P Raju, Prasad Peri, Pratik S Upadhyay, DDC, Qing Joanna Zhou, PhD, Ravi S Harapanhalli, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard E Needham, Robert C Steyert, Robert D Tollefsen, Robert M Barbosa, Robert R Wilson, Rochelie B Young, RPh, MSA, Rumany C Penn, PharmD, Russell K Riley, Ruth Moore, PhD, S Lori Brown, PhD MPH, Samantha J Pinizzotto, D V M, Samina S Khan, Samuel T Walker, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Sarah A Hassas, Satheesh Thomas, Scott B Laufenberg, Scott N Lim, Scott T Ballard, Sergio Chavez (NMI), Seyyida Saterfield, Sharon K Thoma, PharmD, Sheri S Oliver, Sherri J Jackson, Sidney B Priesmeyer, Sneha S Patel, Sripal R Mada, PhD, State Agency, Stephanie A Slater, MS, Stephen D Brown, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Steven E Porter, Jr, Steven Fong, MS, PhD, Steven M Weinman, Steven R Gillenwater, Stuart W Russell, Susanna E Ford, Analyst, Taichun Qin, PhD, Tamara L Ely, Teresa I Navas, Terrence Gee, Terri L Dodds, Terry A Hook, DPh, Thea C Grome, Theressa B Smith, Thomas J Arista, Thomas R Withers, Thomas W Gordon, Thomas W Nojek, Thuy T Nguyen, LCDR, Tiara M Brown, Tiara Nbrown Crosen, Timothy C Grome, Torrance J Slayton, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vaishali J Patel, Vanessa E Coulter, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, William J Leonard, William V Millar, Xikui Chen (nmi), PhD, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zachary A Bogorad

CDR Rochelle B Young, RPh, MSA's Documents

Publish Date Document Type Title
February, 2002 FDA 483 Formulation Technology Incorporated - Form 483, 2002-02-07
March, 2003 EIR SRI International - EIR, 2003-03-12
February, 2000 EIR Rubin, Daniel L., M.D. - EIR, 2000-02-24
April, 2003 EIR Pacific BioLabs - EIR, 2003-04-18
February, 2003 FDA 483 PPD Development LP - Form 483, 2003-02-20
February, 2009 EIR Huashu Pharmaceutical Corporation - EIR, 2009-02-13
May, 2001 EIR James D. Wolfe, M.D. - EIR, 2001-05-03
August, 2003 EIR InterMune, Inc - EIR, 2003-08-27
February, 2001 FDA 483 Marin Biologic - Form 483, 2001-02-02
July, 2003 FDA 483 BPR Health International - Form 483, 2003-07-09
February, 2003 EIR Allergan Sales, LLC - EIR, 2003-02-20
February, 2001 EIR Marin Biologic - EIR, 2001-02-02
January, 2011 EIR BioZone Laboratories Inc. - EIR, 2011-01-31
November, 2003 EIR Bay Bioanalytical Laboratory Inc - EIR, 2003-11-05
November, 2010 EIR Kindeva Drug Delivery L.P. - EIR, 2010-11-05
July, 2003 EIR MedImmune, LLC - EIR, 2003-07-15
April, 2009 FDA 483 BioZone Laboratories, Inc - Form 483, 2009-04-28
November, 2000 FDA 483 St Mary'S Medical Center Irb - Form 483, 2000-11-03
December, 2001 FDA 483 Prima Fleur Botanicals Inc - Form 483, 2001-12-20
August, 2002 EIR ALZA Corporation - EIR, 2002-08-08
January, 2004 EIR Impax Laboratories, LLC. - EIR, 2004-01-29
January, 2001 FDA 483 Instiutional Animal Care and Use Committee at UCSF - Form 483, 2001-01-26
January, 2001 EIR Instiutional Animal Care and Use Committee at UCSF - EIR, 2001-01-26
November, 2000 FDA 483 Response St Mary'S Medical Center Irb - Form 483R, 2000-11-03
March, 2009 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2009-03-20
November, 2002 EIR Alza Corp - EIR, 2002-11-01
March, 2003 FDA 483 SRI International - Form 483, 2003-03-12
May, 2004 EIR Eli Lilly and Company Limited - EIR, 2004-05-06
November, 2000 EIR St Mary'S Medical Center Irb - EIR, 2000-11-03
August, 2003 FDA 483 Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals - Form 483, 2003-08-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more